Mixed-effects modeling of the interspecies pharmacokinetic scaling of oxytetracycline.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Pharmacy and Science

• Publication date

  2002-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/JPS.10001PMID 11835193
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interspecies Scaling of Bosentan, A New Endothelin Receptor Antagonist and Integration of in Vitro Data into Allometric Scaling

  2004cited by this paper
• The Food Animal Residue Avoidance Databank (FARAD). Past, present and future.

  1999cited by this paper
• Preclinical pharmacokinetics and interspecies scaling of a novel vitronectin receptor antagonist.

  1999cited by this paper
• Interspecies scaling of renally secreted drugs.

  1998cited by this paper
• Extralabel use of oxytetracycline.

  1997cited by this paper
• Mixed Effect Modeling of Sumatriptan Pharmacokinetics During Drug Development. I: Interspecies Allometric Scaling

  1997cited by this paper
• Interspecies allometric analysis of the comparative pharmacokinetics of 44 drugs across veterinary and laboratory animal species.

  1997cited by this paper
• Pharmacokinetics of oxytetracycline in goats: modifications induced by a long-acting formulation

  1994cited by this paper
• Allometric analysis of doxycycline pharmacokinetic parameters.

  1990cited by this paper
• Interspecies variation in the plasma halflife of oxytetracycline in relation to bodyweight.

  1990cited by this paper
• The pharmacokinetics of oxytetracycline following intravenous administration in healthy and diseased pigs.

  1990cited by this paper
• Pharmacokinetics of oxytetracycline hydrochloride in rabbits.

  1987cited by this paper
• Interspecies pharmacokinetic scaling and the evolutionary-comparative paradigm.

  1984cited by this paper
• Comparison of pharmacokinetic parameters for two oxytetracycline preparations in pigs.

  1983cited by this paper
• Age-dependent pharmacokinetics of oxytetracycline in ruminants.

  1983cited by this paper
• Oxytetracyclines in cattle. A comparison between a conventional and a long-acting preparation.

  1983cited by this paper
• Distribution of oxytetracycline in the genital tract of cows.

  1982cited by this paper
• Comparative pharmacokinetics of benzodiazepines in dog and man

  1982cited by this paper
• Oxytetracycline hydrochloride in the horse: serum, synovial, peritoneal and urine concentrations after single dose intravenous administration.

  1981cited by this paper
• Some suggestions for measuring predictive performance

  1981cited by this paper
• Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations

  1978cited by this paper
• Interspecies correlation of plasma concentration history of methotrexate (NSC-740).

  1970cited by this paper
• Linear statistical inference and its applications

  1965cited by this paper
• Handbook of Biological Data

  1957cited by this paper

• Determination of pharmacokinetic-pharmacodynamic cutoff values of oxytetracycline in calves and adult cattle using population pharmacokinetic modeling

  2024cites this paper
• Model-based interspecies scaling for predicting human pharmacokinetics of CB 4332, a complement factor I protein.

  2024cites this paper
• Novel αO-conotoxin GeXIVA[1,2] Nonaddictive Analgesic with Pharmacokinetic Modelling-Based Mechanistic Assessment

  2022cites this paper
• Monoclonal Antibodies: From Structure to Therapeutic Application

  2019cites this paper
• Mathematical modeling and simulation in animal health. Part III: Using nonlinear mixed‐effects to characterize and quantify variability in drug pharmacokinetics

  2018cites this paper
• A framework for meta-analysis of veterinary drug pharmacokinetic data using mixed effect modeling.

  2015cites this paper
• Development and application of a multiroute physiologically based pharmacokinetic model for oxytetracycline in dogs and humans.

  2015cites this paper
• Interspecies allometric meta-analysis of the comparative pharmacokinetics of 85 drugs across veterinary and laboratory animal species.

  2015cites this paper
• The application of allometric scaling principles to predict pharmacokinetic parameters across species

  2014cites this paper
• Population Pharmacokinetic Modeling to Predict Withdrawal Times

  2014cites this paper
• Monoclonal Antibodies: From Structure to Therapeutic Application

  2013cites this paper
• Interspecies Modeling and Prediction of Human Exenatide Pharmacokinetics

  2013cites this paper
• Evaluation of factors important in modeling plasma concentrations of tetracycline hydrochloride administered in water in swine.

  2012cites this paper
• Pharmacokinetics of oxytetracycline in hemolymph from the Chinese mitten crab, Eriocheir sinensis.

  2011cites this paper
• Leveraging Pharmacometrics in Early Phase Anti-inflamatory Drug Development

  2011cites this paper
• Comparative pharmacokinetic approaches to estimating the pharmacokinetics of water medications in swine

  2010cites this paper
• Kinetic analysis of oxytetracycline residues in Chinese mitten crab, Eriocheir sinensis, muscle following intramuscular administration.

  2010cites this paper
• The Exposure-Response-Driven Development Program: Application to an Ant i-inflammatory Compound

  2008cites this paper
• Pharmacokinetics of Nanomaterials

  2007cites this paper
• ESTUDIO FARMACOCINETICO DE ANALOGOS DE LA SOMATOSTATINA

  2006cites this paper
• Meta-analysis of pharmacokinetic data of veterinary drugs using the Food Animal Residue Avoidance Databank: oxytetracycline and procaine penicillin G.

  2004cites this paper
• Interspecies considerations in the evaluation of human food safety for veterinary drugs

  2002cites this paper